Q4-FY26 · Ameera Shah
We are not looking at a price increase, but as the things progresses during the year, if there is a need for us to do it, we would not hesitate to do it.
Metropolis Healthcare · tone and specificity signals across the available quarters.
Language signals
We are not looking at a price increase, but as the things progresses during the year, if there is a need for us to do it, we would not hesitate to do it.
We believe a sustainable EBITDA at this point over the next three years of 27 to 28% makes sense for us and if we are able to generate more operating leverage we would like to invest it back in the business.
Our lab addition phase is over... we are not planning to add a high number of labs in the network.